HSA Approval

Mirtazapine Sandoz Orodispersible Tablets 15mg

Approval Number

SIN13643P

Drug Name

Product Name

Mirtazapine Sandoz Orodispersible Tablets 15mg

Approval Date

May 4, 2009

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Licence Holder

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

Registrant

NOVARTIS (SINGAPORE) PTE LTD

Licence Holder

SANDOZ SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route of Administration

ORAL

Medical Information

ATC Code

N06AX11

ATC Item Name

mirtazapine

Manufacturer Information

Pharmaceutical Manufacturer

SANDOZ SINGAPORE PTE. LTD.

Manufacturers

Sandoz Private Limited

Active Ingredients

Ingredient Name

Mirtazapine

Strength

15.0mg

Drug MonographMirtazapine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

Mirtazapine Sandoz Orodispersible Tablets 15mg - HSA Approval | MedPath

AI-Powered Research

Premium Access

Mirtazapine Sandoz Orodispersible Tablets 15mg

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal